BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25829992)

  • 1. Hyperhomocysteinemia and MTHFR polymorphisms as antenatal risk factors of white matter abnormalities in two cohorts of late preterm and full term newborns.
    Marseglia LM; Nicotera A; Salpietro V; Giaimo E; Cardile G; Bonsignore M; Alibrandi A; Caccamo D; Manti S; D'Angelo G; Mamì C; Di Rosa G
    Oxid Med Cell Longev; 2015; 2015():543134. PubMed ID: 25829992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients.
    Fekih-Mrissa N; Mrad M; Klai S; Mansour M; Nsiri B; Gritli N; Mrissa R
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):465-9. PubMed ID: 23642756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Hanson NQ; Aras O; Yang F; Tsai MY
    Clin Chem; 2001 Apr; 47(4):661-6. PubMed ID: 11274015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
    Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5,10-methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine.
    Brown KS; Kluijtmans LA; Young IS; Murray L; McMaster D; Woodside JV; Yarnell JW; Boreham CA; McNulty H; Strain JJ; McPartlin J; Scott JM; Mitchell LE; Whitehead AS
    Atherosclerosis; 2004 Jun; 174(2):315-22. PubMed ID: 15136061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of serum 25-hydroxyvitamin D with serum folate, cobalanin, and homocysteine concentrations and methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in healthy adults.
    Mazokopakis EE; Papadomanolaki MG; Papadakis JA
    Hormones (Athens); 2023 Sep; 22(3):491-499. PubMed ID: 37328700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C.
    Sazci A; Ergul E; Tuncer N; Akpinar G; Kara I
    Brain Res Bull; 2006 Dec; 71(1-3):45-50. PubMed ID: 17113927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.
    Russo GT; Di Benedetto A; Alessi E; Ientile R; Antico A; Nicocia G; La Scala R; Di Cesare E; Raimondo G; Cucinotta D
    J Endocrinol Invest; 2006 Mar; 29(3):201-7. PubMed ID: 16682831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses.
    Mtiraoui N; Zammiti W; Ghazouani L; Braham NJ; Saidi S; Finan RR; Almawi WY; Mahjoub T
    Reproduction; 2006 Feb; 131(2):395-401. PubMed ID: 16452733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic effect of
    Jiang Y; Xiao X; Wen Y; Wan M; Zhou L; Liu X; Wang X; Guo L; Liu H; Zhou Y; Wang J; Liao X; Shen L; Jiao B
    Aging (Albany NY); 2021 Apr; 13(8):11352-11362. PubMed ID: 33833133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Med Oncol; 2011 Dec; 28 Suppl 1():S398-412. PubMed ID: 21046286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia.
    Shmeleva VM; Kapustin SI; Papayan LP; Sobczyńska-Malefora A; Harrington DJ; Savidge GF
    Thromb Res; 2003; 111(6):351-6. PubMed ID: 14698652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.
    Russo GT; Di Benedetto A; Magazzù D; Giandalia A; Giorda CB; Ientile R; Previti M; Di Cesare E; Cucinotta D
    Acta Diabetol; 2011 Jun; 48(2):95-101. PubMed ID: 19937354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children.
    Aléssio AC; Höehr NF; Siqueira LH; Bydlowski SP; Annichino-Bizzacchi JM
    Thromb Res; 2007; 119(5):571-7. PubMed ID: 16820193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
    Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K
    Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism.
    Joachim E; Goldenberg NA; Bernard TJ; Armstrong-Wells J; Stabler S; Manco-Johnson MJ
    Thromb Res; 2013 Aug; 132(2):170-4. PubMed ID: 23866722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
    Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.